Better Modulate, Measure and Predict Immune Response to Gene Therapies
Gene therapies are revolutionizing the therapeutic landscape for rare and inherited diseases. For the field to progress, however, there are several unique and complex challenges. Perhaps the most prominent of these challenges is the immune response to gene therapy delivery.
Gene Therapy Immunogenicity is the industry’s definitive digital forum enabling you to better measure, modulate, and predict immune response to your gene therapy candidate.
Virtually uniting industry leaders across the gene therapy space, this multi-disciplinary forum will enable you to develop more effective and safe gene therapies by discussing how you can:
- Identify and tailor novel capsid proteins for more specific targeting and immunologic evasion
- Reduce AAV neutralizing antibodies
- Confidently assess immunosuppression strategies to dampen immune response
As the only online conference dedicated to the immunogenicity of gene therapies, this will be an unrivaled opportunity to join 80+ like-minded thought-leaders from cross-disciplines to foster new connections and partnerships.
Download the full event guide to learn more.
Our previous attendees have said:
“Inspiring virtual meeting allowing efficient learning about the most recent advances in gene therapy immunogenicity while still having interactions with peers.”
Cornelia Ciorciaro, Director - Safety Science Group Medical, Roche
“It was great to have a conference focused on analytical challenges for testing immune markers and modulating immune responses to gene therapies.”
Michele Stone, Vice President - Translational Development, Kriya Therapeutics
“I learned a lot about the what, who & how of the AAV gene therapy field.”
Robert J Kubiak, Clinical Pharmacologist, AstraZeneca